KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Evolent Health (EVH) Return on Sales (2016 - 2025)

Evolent Health (EVH) has 11 years of Return on Sales data on record, last reported at 22.58% in Q4 2025.

  • For Q4 2025, Return on Sales rose 2261.0% year-over-year to 22.58%; the TTM value through Dec 2025 reached 0.38%, down 36.0%, while the annual FY2025 figure was 9.3%, N/A changed from the prior year.
  • Return on Sales reached 22.58% in Q4 2025 per EVH's latest filing, up from 0.04% in the prior quarter.
  • Across five years, Return on Sales topped out at 22.58% in Q4 2025 and bottomed at 0.13% in Q1 2025.
  • Average Return on Sales over 5 years is 1.1%, with a median of 0.03% recorded in 2024.
  • The widest YoY moves for Return on Sales: up 2261bps in 2025, down -11bps in 2025.
  • A 5-year view of Return on Sales shows it stood at 0.01% in 2021, then tumbled by -341bps to 0.03% in 2022, then increased by 22bps to 0.02% in 2023, then crashed by -53bps to 0.04% in 2024, then skyrocketed by 64060bps to 22.58% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Sales were 22.58% in Q4 2025, 0.04% in Q3 2025, and 0.04% in Q2 2025.